Learn more about our Advocacy work.
Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of…
Washington, D.C.– AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Get expert insights, key documents, and event details on trade and policy shifts.
Exclusive member webinar on tariffs, customs, USMCA rules of origin, and compliance strategies with expert Larry Friedman. Air Date April 4, 2025. Now On Demand!
Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of…
Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Hear from Multistate policy experts Joe Rinzel and Townsend Brown as they discuss state product stewardship and producer responsibility policy trends.
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.